Tuberculosis Trials Consortium. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients : a randomized clinical trial
収録刊行物
-
- Lancet
-
Lancet 360 528-534, 2002


